Conmed to exit gastroenterology business
As part of the strategic pivot, Conmed will double down on core markets and drop VIABIL stent rights.
08 December 2025
08 December 2025
As part of the strategic pivot, Conmed will double down on core markets and drop VIABIL stent rights.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.